Prospective Multi-Institutional Study of Eculizumab to Treat High-Risk Stem Cell Transplant Associated TMA. Jodele S, Dandoy CE, Aguayo-Hiraldo P, Lane A, et al. Blood 2023 Nov 9:blood.2023022526. doi: 10.1182/blood.2023022526.

Read + Share

Amedeo Smart

Independent Medical Education

Jodele S, Dandoy CE, Aguayo-Hiraldo P, Lane A, et al. Prospective Multi-Institutional Study of Eculizumab to Treat High-Risk Stem Cell Transplant Associated TMA. Blood 2023 Nov 9:blood.2023022526. doi: 10.1182/blood.2023022526.
PMID: 37946262